Russian Journal of Skin and Venereal DiseasesRussian Journal of Skin and Venereal Diseases1560-95882412-9097Eco-Vector6237710.17816/dv62377Research ArticleLyell´s syndrome provoked by external drug useKrivosheevAlexandr B.<p>Dr. Sci. (Med.), Professor</p>krivosheev-ab@narod.ruhttps://orcid.org/0000-0002-4845-8753ErmachenkoTamara V.<p>MD</p>ermat@mail.ruhttps://orcid.org/0000-0003-4725-7308KhavinPavel P.<p>Sci. (Med.)</p>terapia@mail.ruhttps://orcid.org/0000-0002-5501-0543KrivosheevaInga A.<p>Cand. Sci. (Med.)</p>terapia@mail.ruhttps://orcid.org/0000-0002-3575-4983MorozovDmitry V.<p>Cand. Sci. (Med.)</p>mdvil07@mail.ruhttps://orcid.org/0000-0003-1773-7140Novosibirsk State Medical UniversityCity Clinical Hospital No 1City Clnical Hospital No 11502202124125340103202117032021Copyright © 2021, Eco-Vector2021<p>Lyells syndrome is rare. Up to 10 cases are registered per million population per year. The mortality rate for Lyells syndrome is 512%.</p>
<p>Two patients were observed aged, respectively, 38 years and 72 years with Lyells syndrome. The disease manifested itself against the background of local application of drugs. In one case ― Dolobens gel as an analgesic at the site of a bruise of the right hand. In another case, a 20% solution of chlorohxidin biogluconate as a mouth rinse for stomatitis. The first symptoms of the disease occurred locally at the site of application of these medicines. In the first case, the skin of the right hand, in the second ― the mucous membrane of the mouth. The outcome of the disease depended on early diagnosis, urgent hospitalization in a specialized department, from the area of skin lesions, the appointment of adequate therapy.</p>
<p>Lyells syndrome can occur at any age, and the risk of developing the disease increases in those over the age of 40. In the elderly, SL in terms of the first symptoms and rate of disease progression, the nature of skin and mucous membrane lesions does not have any fundamental differences with those in younger patients. The distinctive features and risk factors of Lyells syndrome in the elderly include, firstly, its occurrence against the background of the already formed comorbid age-related pathology of internal organs, secondly, the concomitant age-related pathology during the development of an acute toxic-allergic reaction is decompensated, a multiorgan failure is formed, which is the cause of more severe Lyells syndrome and higher mortality. In young people, a comorbid viral infection can be considered a risk factor, especially the combination of HIV-infection and chronic hepatitis C.</p>Lyell’s syndromecomorbid pathology of internal organsHIV-infectionchronic hepatitis Cсиндром Лайеллакоморбидная патология внутренних органовВИЧ-инфекцияхронический гепатит С[Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol. 1956;68(11):355–361. doi: 10.1111/j.1365-2133.1956.tb12766.x][Krivosheev BN, Mezhberg LB, Ronzhina ZG, Kovalevskaya MG. Toxic epidermal necrolysis ― Lyell’s syndrome. Clinical Medicine. Russian Journal. 1972;(6):126–130. (In Russ).][Butov YuS, Skripkin YuK, Ivanov OL, eds. Dermatovenereology. National leadership. Moscow: GEOTAR-Media; 2013. 1021 р. (In Russ).][Khokhlova ZA, Gileva RA, Konyakhina IG, Tishkina AP. Lyell’s syndrome. Practical case. Rus Arch Inter Med. 2018;8(3):231–236. (In Russ).][Fitzpatrick T, Johnson R, Wolfe K, et al. Dermatology according to Thomas Fitzpatrick: Atlas-handbook. Trans. from English. E.A. Okisheva, A.V. Snegovskaya, E.R. Timofeeva. 2nd Russian ed. Moscow: Praktika; 2007. 1248 p.][Krivosheev BN, Kuimov AD, Krivosheev AB, Morozov DV. Lyell’s syndrome in the elderly. Russian Journal of Skin and Venereal Diseases. 2009;12(6):10–18. (In Russ).][Kudo T, Nakajima K, Shiga T, et al. Successful treatment for toxic epidermal necrolysis / drug-induced hypersensitivity syndrome overlap with corticosteroids, intravenous immunoglobulins and plasma exchange. J Clin Exp Dermatol Res. 2014;5(3):216–218. doi: 10.1016/j.jds.2015.03.008][Lyell A. A review of toxic epidermal necrolysis in Britain. Br J Dermatol. 1967;79(12):662–671. doi: 10.1111/j.1365-2133.1967.tb11434.x][Krivosheev BN, Kuimov AD, Krivosheev AB, et al. Lyell’s sindrome provoked by biologically active food additive. Russian Journal of Skin and Venereal Diseases. 2007;10(3):48–51. (In Russ).][Koudelka EN, Shakhmatov DM, Sobolev AF, et al. Toxic epidermal necrolysis (Lyell’s Syndrome). Russian Journal of Infektology. 2017;9(4):144–152. (In Russ).][Lyell A. Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal. Br J Dermatol. 1979;100(1):69–86. doi: 10.1111/j.1365-2133.1979.tb03571.x][Es H, Arslan MN, Yagmur G, Karayel FA. Toxic epidermal necrolysis like bullous skin reaction: an autopsy case. Turkish J Foren Med. 2015;29(2):118–123. doi: 10.5505/adlitip.2015.28190][Krivosheev BN, Tonsheva LN, Samoteykina YuM, Shakhmatov DA. Of a complication at external use of Furacilin. Soviet Medicine. Russian Journal. 1990;(12):87–90. (In Russ).][Homich FA, Podobed YuI. Ostry toxic epidermalny nekroliz. Health Care of Belarus. 1968;(2):87. (In Russ).][Zaslavsky DV, Gorlanov IA, Samtsov AV, Khairutdinov VR. Federal clinical recommendation on patients with Steven-Johnson syndrome / Toxic epidermal necrolysis. Moscow: Russian Dermatovenerologists and Cosmetologists Society; 2015. (In Russ). Available from:][https://www.ismos.ru/guidelines/doc/sindrom_stivenca-dzhonsona.pdf][Halevy S, Ghislain PD, Mockenhaupt M, et al.; EuroSCAR Study Group. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol. 2008;58(1):25–32. doi: 10.1016/j.jaad.2007.08.036][Mockenhaupt M, Viboud C, Dunant A, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risk with emphasis on recently marketed druds. The EuroSCAR-study. J Invest Dermatol. 2008;128(1):35–44. doi: 10.1038/sj.jid.5701033][Tezyaeva SA, Mlinnik RA, Degtyareva SF, et al. Lyell’s Syndrome as a rare complication of drug therapy (clinical cases). Medial. 2015;2(16):42–45. (In Russ).][Toxic epidermal necrolysis (Stevens-Johnson syndrome). Clinical recommendation. Moscow; 2016. (In Russ). Available from: https://medi.ru/klinicheskie-rekomendatsii/nekroliz-toksicheskij-epidermalnyj-sindrom-stivensa-dzhonsona_14105/][Auquier-Dunant A, Mockenhaupt M, Naldin L, et al.; SCAR Study Group. Severe Cutaneous Adverse Reactions. Correlation between clinical patterns and causes of erythema multiforme major, Stevens Johnson syndrome and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol. 2002;138(8):1019–1024. doi: 10.1001/archderm.138.8.1019][Conroy RM, Pyorala K, Fitzgerald AP, et al.; SCORE project group. Estimation of ten-year risk of total cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24(11):987–1003. doi: 10.1016/s0195-668x(03)00114-3][Huseyin E, Murat NA, Gulhan Y. Toxic epidermal necrolysis like bullous skin reaction: an autopsy case. J For Med Gut. 2014;29(2):118–123. doi: 10.5505/adlitip.2015.28190]